PNEUMOCYSTIS JIROVECII PNEUMONIA IN HOSPITALIZED CANCER PATIENTS: INCIDENCE, RISK FACTORS, AND PROPHYLAXIS

被引：0
|
作者：
Van Hook, Reed
Mantha, Aditya
Rhoads, Sarah L.
Spradlin, Megan
Pons, Shelby
Mccollister, Bruce
Mueller, Scott
Kannappan, Arun
Maloney, James P.
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.597
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：801A / 802A
页数：2
相关论文
共 50 条
  • [31] Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: A systematic review
    Sierra, Caroline M.
    Daiya, Krishna C.
    PHARMACOTHERAPY, 2022, 42 (11): : 858 - 867
  • [32] Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients
    Lee, Su Hwan
    Huh, Kyu Ha
    Joo, Dong Jin
    Kim, Myoung Soo
    Kim, Soon Il
    Lee, Juhan
    Park, Moo Suk
    Kim, Young Sam
    Kim, Se Kyu
    Chang, Joon
    Kim, Yu Seun
    Kim, Song Yee
    SCIENTIFIC REPORTS, 2017, 7
  • [33] Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study
    Viceconte, Giulio
    Buonomo, Antonio Riccardo
    D'Agostino, Alessia
    Foggia, Maria
    Di Fusco, Antonio
    Pinchera, Biagio
    Scotto, Riccardo
    Iacovazzo, Carmine
    Fanasca, Luca
    Messina, Gaetana
    Cacciatore, Francesco
    Salvatore, Paola
    Gentile, Ivan
    JOURNAL OF FUNGI, 2023, 9 (08)
  • [34] In Search of Clinical Factors That Predict Risk for Pneumocystis jirovecii Pneumonia in Patients without HIV/AIDS
    Limper, Andrew H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (12) : 1467 - 1468
  • [35] Incidence And Risk Factors For Development Of Delirium In Hospitalized Patients With Pneumonia
    Nishimura, N.
    Yamada, U.
    Ogino, H.
    Suzuki, S.
    Okafuji, K.
    Kitamura, A.
    Tomishima, Y.
    Jinta, T.
    Chohnabayashi, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [36] The value of Pneumocystis jirovecii pneumonia prophylaxis in the era of personalized medicine
    Kronbichler, Andreas
    Gauckler, P.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2020, 49 (05) : 343 - 344
  • [37] Outbreak of Pneumocystis Jirovecii Pneumonia Despite the Use of Routine Prophylaxis
    Sandes-Freitas, T. V.
    Silva, V. P.
    Oliveira, F. S. V.
    Franco, M. F.
    Tedesco-Silva, H.
    Medina-Pestana, J. O.
    TRANSPLANTATION, 2012, 94 (10) : 553 - 553
  • [38] Pneumocystis jirovecii pneumonia and invasive fungal infection incidence and institutional prophylaxis practices in CLL patients treated with BTK inhibitors
    Ryan, Christine
    Cheng, Matthew
    Issa, Nicolas
    Brown, Jennifer
    Davids, Matthew
    LEUKEMIA & LYMPHOMA, 2020, 61 : 21 - 22
  • [39] Pneumocystis jirovecii pneumonia prophylaxis for HIV-exposed neonates
    Bennett, Nicholas J.
    RESEARCH AND REPORTS IN NEONATOLOGY, 2014, 4 : 71 - 74
  • [40] Risk factors for prophylaxis failure in patients receiving aerosol pentamidine for Pneumocystis carinii pneumonia prophylaxis
    Wei, CCY
    Gardner, S
    Rachlis, A
    Pack, LL
    Chan, CKN
    CHEST, 2001, 119 (05) : 1427 - 1433
12345